M. genitalium detected n (%) |
M. genitalium not detected n (%) | OR (95% CI) | P value | |
Age (years) | 2.3 (0.5 to 10.7) | 0.2783 | ||
<25 | 2/49 (4.1) | 47/49 (95.9) | ||
≥25 | 12/135 (8.9) | 123/135 (91.1) | ||
Sex of partner/s | 0.7 (0.2 to 2.0) | 0.4654 | ||
Male | 7/109 (6.4) | 102/109 (93.6) | ||
Female | 7/75 (9.3) | 68/75 (90.7) | ||
Sexual partners last 3 months (n) | ||||
Male* | 1.7 (0.4 to 6.7) | 0.4425 | ||
0–1 | 0/14 (0.0) | 14/14 (100.0) | ||
2–5 | 3/54 (5.6) | 51/54 (94.4) | ||
≥6 | 2/32 (6.3) | 30/32 (93.8) | ||
Female† | 1.5 (0.4 to 5.5) | 0.534 | ||
0–1 | 1/19 (5.7) | 18/19 (94.7) | ||
2–5 | 5/46 (10.9) | 41/46 (89.1) | ||
≥6 | 1/9 (11.1) | 8/9 (88.9) | ||
Condom use last 3 months | ||||
Never | 9/82 (11.0) | 73/82 (89.0) | 1.7 (0.8 to 3.8) | 0.1799 |
Sometimes/usually | 4/75 (5.3) | 71/75 (94.5) | ||
Always/no vaginal or anal sex | 1/22 (4.6) | 21/22 (95.5) | ||
PrEP‡, MSM only | 3.6 (0.6 to 23.3) | 0.1523 | ||
Yes | 3/31 (9.7) | 28/31 (90.3) | ||
No | 2/69 (2.9) | 67/69 (97.1) | ||
Urethral CT | 0.4 (0.1 to 3.1) | 0.3585 | ||
Yes | 1/29 (3.5) | 28/29 (96.6) | ||
No | 13/155 (8.4) | 142/155 (91.6) | ||
HIV seropositive | 0.5087 | |||
Yes | 0/5 (0.0) | 5/5 (100.0) | ||
No | 14/173 (8.1) | 159/173 (91.9) | ||
NG anorectal | 0.8 (0.1 to 4.8) | 0.8239 | ||
Yes | 2/38 (5.3) | 4/65 (6.2) | ||
No | 36/38 (94.7) | 61/65 (93.9) | ||
NG oropharyngeal | 0.4 (0.1 to 3.8) | 0.4173 | ||
Yes | 1/32 (3.1) | 6/75 (8.0) | ||
No | 31/32 (96.9) | 69/75 (92.0) | ||
CT anorectal | 1.9 (0.2 to 18.5) | 0.5692 | ||
Yes | 1/10 (10.0) | 5/93 (5.4) | ||
No | 9/10 (90.0) | 88/93 (94.6) | ||
CT oropharyngeal | 3.60 (0.3 to 37.0) | 0.2541 | ||
Yes | 1/6 (16.7) | 6/102 (5.9) | ||
No | 5/6 (83.3) | 96/102 (94.1) |
*Among MSM.
†Among heterosexual men.
‡PrEP, on HIV pre-exposure prophylaxis.
CT, Chlamydia trachomatis; MSM, men who have sex with men; NG, Neisseria gonorrhoeae.